Searching News Database: Synthetic Biologics
HSMN NewsFeed - 12 Nov 2020
Synthetic Biologics Welcomes Senior Biotech Executive John Monahan, PhD, to Board of Directors
Synthetic Biologics Welcomes Senior Biotech Executive John Monahan, PhD, to Board of Directors
HSMN NewsFeed - 3 Jan 2019
Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company
Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company
HSMN NewsFeed - 12 Sep 2017
Synthetic Biologics Announces Closing of $12 Million Convertible Preferred Stock Financing
Synthetic Biologics Announces Closing of $12 Million Convertible Preferred Stock Financing
HSMN NewsFeed - 11 May 2016
Isaac J. Bright, MD, Joins Synthetic Biologics as Vice President, Corporate Development
Isaac J. Bright, MD, Joins Synthetic Biologics as Vice President, Corporate Development
HSMN NewsFeed - 9 May 2016
Synthetic Biologics Appoints Deb Mathews, PharmD, as Vice President, Medical Affairs
Synthetic Biologics Appoints Deb Mathews, PharmD, as Vice President, Medical Affairs
HSMN NewsFeed - 1 Oct 2015
Synthetic Biologics Appoints Raymond Stapleton, PhD, as Senior Vice President, Manufacturing
Synthetic Biologics Appoints Raymond Stapleton, PhD, as Senior Vice President, Manufacturing
HSMN NewsFeed - 12 Jun 2013
RTI Biologics(R) Announces Agreement to Acquire Pioneer(R) Surgical Technology
RTI Biologics(R) Announces Agreement to Acquire Pioneer(R) Surgical Technology
HSMN NewsFeed - 14 May 2012
Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
Additional items found! 1
Members Archive contains
1 additional stories matching:
Synthetic Biologics
(Password required)
Synthetic Biologics
(Password required)